Peptide-based diagnostic antibodies for Diabetes
Category
Diagnostics and Personalised Medicine
Register type
Biotech Sanitaria
Company name
Product / Service
Peptide-based diagnostic antibodies for Diabetes
Type
Diagnostic
Therapeutic area
Trastornos metabólicos / Endocrinología
Properties/Indication
High-specificity monoclonal antibodies targeting insulin, proinsulin and C-peptide, designed for sensitive, selective and reproducible detection of key diabetes biomarkers. These antibodies are engineered to achieve high affinity and minimal cross-reactivity, with a design optimized for integration into ultrasensitive immunoassay technologies. The program aims to support accurate evaluation of pancreatic function, endogenous insulin secretion and disease progression in diabetes and related metabolic disorders.
Application
Intended for use as in vitro diagnostic reagents in diabetes testing, with application in ultrasensitive immunoassays for biomarker quantification. Use cases include integration into diagnostic platforms, assay development and validation, clinical research, and use as analytical or reference reagents for monitoring insulin, proinsulin and C-peptide levels in biological samples.
Development phase
R&D
Phases developed in Spain
R&D
Research location
España